000			02284cam a2200349 a 4500
003			EG-GiCUC
005			20250223031346.0
008			151202s2015 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.15.M.Sc.2015.Mo.E
100	0		_aMohamed Medhat Mohamed Morsi
245	1	4	_aThe effect of consecutive heparin {u2013} coumarin {u2013} heparin as an anti-coagulatnt protocol for pregnant women with prosthetic valve replacement on maternal, fetal and neonatal outcome / _cMohamed Medhat Mohamed Morsi ; Supervised Reda Ismail Reyad , Aml Hanafy Hussien , Rasha Omar Alkomy
246	1	5	_aتأثير استعمال البروتوكول المتتابع من الهيبارين ثم الكومارين ثم الهيبارين كمضاد للتخثر على حالة الأم والجنين و الأطفال حديثى الولادة فى حالات الحمل التى قامت بتغيير صمامات بالقلب
260			_aCairo : _bMohamed Medhat Mohamed Morsi , _c2015
300			_a85 P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics
520			_aThis study was conducted on 40 pregnant women with prosthetic mitral valve on anticoagulant therapy. Our cases were either followed up or hospitalized in high risk pregnancy unit Kasr El-Aini hospital, Cairo University to investigate the outcome of pregnancy as regard fetal and maternal morbidity and mortality.We found that 10% of our cases had hemorrhagic complications, and neonatal complications were 5.3%. We concluded that the best approach to manage such patients is unfractionated heparin in the first trimester then warfarin till 36th week guided by INR then unfractionated heparin till delivery
530			_aIssued also as CD
653		4	_aAnticoagulant
653		4	_aMitral valve prosthesis
653		4	_aOutcome of pregnancy
700	0		_aAml Hanafy Hussien , _eSupervisor
700	0		_aRasha Omar AlKomy , _eSupervisor
700	0		_aReda Ismail Reyad , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aEnas _eCataloger
905			_aNazla _eRevisor
942			_2ddc _cTH
999			_c53682 _d53682